Gene study for children with new immune low platelet disorder
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks at a gene (CTLA-4) that may affect how the immune system works in children with a new diagnosis of ITP. By understanding this gene, researchers hope to learn more about ITP and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have a new diagnosis of ITP, meaning the low platelets were found recently (within about 3 months).
- The ITP must be primary, meaning it’s not caused by another illness or infection.
- The person must be older than 1 year and younger than 18 years old.
- You must be willing to sign a consent form to participate.
- Both boys and girls can join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects data from people with immune thrombocytopenia (a condition where the immune system destroys platelets, causing low blood counts). It aims to better understand and track the disease over time.
This trial tests a new type of immune cell therapy (CAR-T cells) for people with chronic or refractory immune thrombocytopenia (ITP), a condition where the immune system destroys platelets. The goal is to see if this treatment can safely raise platelet counts and reduce bleeding risk.
This trial tests a new medicine for children with a condition called immune thrombocytopenia (ITP), which causes low blood platelets and easy bruising or bleeding. It may help increase platelet counts when standard treatments haven't worked.
This study looks at how the immune system goes wrong at the very start of two autoimmune conditions in children: ITP (low blood platelets causing bruising) and lupus (which can affect skin, joints, and organs). Researchers will compare blood samples from patients and healthy children to find early signs of disease, with the goal of better understanding and treating these conditions.
This study looks at blood and immune system patterns in adults with primary immune thrombocytopenia (ITP) who are starting their first treatment. The goal is to better understand what’s happening in ITP, which may improve how future patients are cared for.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
Hear when a new ITP - Immune Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.